Open AccessA presumed case of Darbepoetin‐induced myocardial infarction in the patient with MDS‐RARS
Author(s) -
Zafar Aneeqa Ahsan,
Kouides Peter
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2728
Subject(s) - medicine , erythropoietin , myocardial infarction , darbepoetin alfa , intensive care medicine , cardiology
Abstract Our case is only the 2nd such reported case of atherothrombosis from ESAs and highlights the increased risk of cardiovascular events in patients receiving erythropoietin‐stimulating agents specially patients with underlying MDS where targeting a lower hemoglobin goal and optimizing other cardiovascular risk factors might be beneficial in preventing future cardiovascular mortality.